drugset / Trial / NCT06876116
Once-daily Fluorometholone vs Twice-daily Cyclosporine in Dry Eye Disease
Phase 4
Completed
32 enrolled
Korea University Anam Hospital
Taejoon Pharmaceutical Co., Ltd. · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
This study compares the therapeutic effects of once-daily fluorometholone 0.1% versus twice-daily cyclosporine 0.05% after short-term fluorometholone induction treatment in dry eye disease.
Timeline
- Start
- 2022-09-01
- Primary completion
- 2024-03-01
- Completion
- 2024-05-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Cyclosporine | Peptide | 0.05 % | Other |
| Comparator | Fluorometholone | Other / unclassified | 0.1 % | Other |